Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Paul Maria Jansen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Lancet. HIV|January 15, 2016
PrEP: why we are waitingMaarten Paul Maria Jansen, Noor Tromp, Rob Baltussen
Lancet (London, England)|March 31, 2016
Time to recognise countries' preferences in HIV controlNoor Tromp, Rozar Prawiranegara, Adiatma Siregar, et al.
The Lancet. Global Health|July 16, 2019
A sustainable approach to universal health coverageMaarten Paul Maria Jansen, Leon Bijlmakers, Rob Baltussen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative ProcessesRob Baltussen, Maarten Paul Maria Jansen, Leon Bijlmakers, et al.
Vaccine|September 26, 2025
Health economics and vaccine financing in the eastern Mediterranean region: A needs assessmentPalwasha Anwari, Gerald Sume, Wedyan Meshreky, et al.
Vaccines|September 28, 2024
Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine CountriesMateusz Hasso-Agopsowicz, Dijana Spasenoska, Maarten Paul Maria Jansen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Lancet. HIV|January 15, 2016
PrEP: why we are waitingMaarten Paul Maria Jansen, Noor Tromp, Rob Baltussen
Lancet (London, England)|March 31, 2016
Time to recognise countries' preferences in HIV controlNoor Tromp, Rozar Prawiranegara, Adiatma Siregar, et al.
The Lancet. Global Health|July 16, 2019
A sustainable approach to universal health coverageMaarten Paul Maria Jansen, Leon Bijlmakers, Rob Baltussen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative ProcessesRob Baltussen, Maarten Paul Maria Jansen, Leon Bijlmakers, et al.
Vaccine|September 26, 2025
Health economics and vaccine financing in the eastern Mediterranean region: A needs assessmentPalwasha Anwari, Gerald Sume, Wedyan Meshreky, et al.
Vaccines|September 28, 2024
Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine CountriesMateusz Hasso-Agopsowicz, Dijana Spasenoska, Maarten Paul Maria Jansen, et al.
Pageof 1